Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 43,366 | 39,103 | 44,329 | 51,840 | 48,634 |
| Cost of Goods | 31,941 | 23,970 | 27,414 | 30,921 | 30,337 |
| Gross Profit | 11,425 | 15,133 | 16,915 | 20,919 | 18,297 |
| Operating Expenses | 10,413 | 18,474 | 10,815 | 10,795 | 10,278 |
| Operating Income | 1,953 | -2,371 | 6,514 | 11,045 | 8,356 |
| Other Income | 753 | 588 | 424 | 387 | 203 |
| Pre-tax Income | 2,706 | -1,783 | 6,938 | 11,432 | 8,559 |
| Income Tax | 812 | -840 | 2,565 | 4,138 | 2,962 |
| Net Income Continuous | 1,894 | -943 | 4,373 | 7,294 | 5,597 |
| Net Income | $1,894 | $-943 | $4,373 | $7,294 | $5,597 |
| EPS Basic Total Ops | 0.06 | -0.04 | 0.14 | 0.23 | 0.18 |
| EPS Basic Continuous Ops | 0.06 | -0.03 | 0.14 | 0.23 | 0.18 |
| EPS Diluted Total Ops | 0.06 | -0.03 | 0.13 | 0.23 | 0.17 |
| EPS Diluted Continuous Ops | 0.06 | -0.03 | 0.13 | 0.23 | 0.17 |
| EBITDA(a) | $5,629 | $1,612 | $10,285 | $14,873 | $12,293 |